RELATIONSHIP OF CYP2D6 (DEBRISOQUINE HYDROXYLASE) GENOTYPE TO BREAST-CANCER SUSCEPTIBILITY

被引：23

作者：

BUCHERT, ET

WOOSLEY, RL

SWAIN, SM

OLIVER, SJ

COUGHLIN, SS

PICKLE, L

TROCK, B

RIEGEL, AT

机构：

[1] GEORGETOWN UNIV,MED CTR,DEPT PHARMACOL,3900 RESERVOIR R D W,WASHINGTON,DC 20007

[2] NATL CTR HLTH STAT,HYATTSVILLE,MD 20782

[3] GEORGETOWN UNIV,MED CTR,DEPT MED,WASHINGTON,DC 20007

[4] GEORGETOWN UNIV,MED CTR,VT LOMBARDI CANC RES CTR,WASHINGTON,DC 20007

来源：

PHARMACOGENETICS | 1993年 / 3卷 / 06期

关键词：

D O I：

10.1097/00008571-199312000-00006

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：322 / 327

页数：6

共 18 条

[1] DEBRISOQUINE SPARTEINE HYDROXYLATION GENOTYPE AND PHENOTYPE - ANALYSIS OF COMMON MUTATIONS AND ALLELES OF CYP2D6 IN A EUROPEAN POPULATION [J].

BROLY, F ;

GAEDIGK, A ;

HEIM, M ;

EICHELBAUM, M ;

MORIKE, K ;

MEYER, UA .

DNA AND CELL BIOLOGY, 1991, 10 (08) :545-558

[2] RELEVANCE OF METABOLIC POLYMORPHISMS TO HUMAN CARCINOGENESIS - EVALUATION OF EPIDEMIOLOGIC EVIDENCE [J].

CAPORASO, N ;

LANDI, MT ;

VINEIS, P .

PHARMACOGENETICS, 1991, 1 (01) :4-19

[3]

COPORASO NE, 1990, J NATL CANCER I, V82, P1264

[4]

HANIOKA N, 1990, AM J HUM GENET, V47, P994

[5] GENOTYPING OF POOR METABOLIZERS OF DEBRISOQUINE BY ALLELE-SPECIFIC PCR AMPLIFICATION [J].

HEIM, M ;

MEYER, UA .

LANCET, 1990, 336 (8714) :529-532

[6] METABOLISM OF DEBRISOQUINE AND SUSCEPTIBILITY TO BREAST-CANCER [J].

HUOBER, J ;

BERTRAM, B ;

PETRU, E ;

KAUFMANN, M ;

SCHMAHL, D .

BREAST CANCER RESEARCH AND TREATMENT, 1991, 18 (01) :43-48

[7]

KAGIMOTO M, 1990, J BIOL CHEM, V265, P17209

[8]

KAISARY A, 1987, CANCER RES, V47, P5488

[9]

KIMURA S, 1989, AM J HUM GENET, V45, P889

[10]

KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES

← 1 2 →